A new exhibition series rejects the question of whether or not we should be doing drugs, and instead tries to understand why, and how, we always have.

Perhaps an even more surefire way to land on the far side of that threshold is to tell them about your trip on one of the most bizarre, powerful, and under-studied psychedelic drugs: DMT ...

Our bachelor's degree in Design, Merchandising and Textiles (DMT) offers students the education they need to enter a diverse and competitive field in which individuals plan, provide, and promote ...

A street art project aiming to transform Abu Dhabi's public spaces into stunning canvasses has been expanded to feature more ...

Participants will be given the drug DMT, followed by talking therapy. It is hoped this could offer an alternative for the significant number of people who don't respond to conventional pills for ...

DMT is the major psychoactive compound in ayahuasca, a drink made from vines The effects of a powerful psychedelic drug are similar to a near-death experience, research suggests. Answers to a ...

They can include music therapy, art therapy, dance therapy, and more. The healing arts are a type of complementary therapy, which means people can use them alongside standard medical treatments to ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Small Pharma is the first company to conduct clinical trials to treat depression with the psychedelic N,N-dimethyltryptamine (DMT). “Combining pharmacological and psychological intervention is a ...

dimethyltryptamine (DMT), mescaline, and ibogaine. I would create psychedelic therapy centers across the state where folks could purchase and use the substances under supervision of licensed ...

Maybe you’ve seen him, campaigning for President across San Diego…On his third run for the Presidency now, Frank Barish has ...

On 23 October 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s anti-amyloid beta (Aβ) monoclonal antibody (mAb) Kisunla for the treatment of patients with mild ...